Endocrinology and Clinical Metabolic Research
A section of Metabolites (ISSN 2218-1989).
Section Information
Metabolites and metabolism have long been key parts of endocrinology and clinical metabolic research. This section of Metabolites now provides a venue to focus on these areas of investigation. In addition to those areas of traditional interest, such as precision medicine, biomarker discovery and inborn errors of metabolism, other clinically relevant areas will also be given full consideration.
These include, but are not limited to, original research and review articles on:
- metabolism in endocrine disorders
- cardio-metabolic risk
- fatty liver disease (NAFLD-NASH/MAFLD); cryptogenic and NAFLD-cirrhosis; NAFLD-HCC
- chronic kidney disease; fatty pancreas and gut microbiota
- adiposopathy and pathophysiology of adipose tissue
- immunity and metabolism
- metabolic derangements in infectious diseases
- sex medicine as applied to normal and deranged metabolism
- lifestyle and metabolism; chronometabolism; intermittent fasting
- biochemical and molecular characterization of pathophenotypes in internal medicine
In all these areas and many others, multidisciplinary and molecular approaches will represent added value. We hope our readers will appreciate the section “Endocrinology and Clinical Metabolic Research” and look forward to receiving high-quality scientific submissions from all over the world, while committing ourselves to the rapid and accurate processing of manuscripts.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Puberty and the Metabolic Syndrome (Deadline: 15 December 2024)
- Molecular Mechanisms in Cancer, Cardiovascular and Metabolic Diseases: Potential Therapies and Treatments (Deadline: 18 December 2024)
- Exploring Pathological Mechanisms in Obesity, Diabetes, and Metabolic Syndrome (Deadline: 20 December 2024)
- Diabetes and Metabolic Diseases: From Prevention to Clinical Management (Deadline: 31 December 2024)
- Metabolomics in Chronic Disease (Deadline: 31 December 2024)
- Metabolic Programming of Hepatic Organ Function—2nd Edition (Deadline: 31 December 2024)
- Energy Metabolism in Neurodegenerative Diseases (Deadline: 31 December 2024)
- Liver Injury and Regeneration—Metabolic Research (Deadline: 31 December 2024)
- Immunoregulatory Metabolites with Clinical Relevance (Deadline: 31 December 2024)
- Effects of the Glutamatergic System on Metabolic Alterations (Deadline: 31 December 2024)
- Effects of Exercise on Cardiooncology and Cancer Metabolism (Deadline: 4 January 2025)
- Obesity and Metabolic Health (Deadline: 5 January 2025)
- Metabolic Insights into Pediatric Overweight and Obesity: Mechanisms, Impacts and Interventions (Deadline: 15 January 2025)
- The Role of Hepatic Insulin Clearance in Obesity and Type 2 Diabetes (Deadline: 31 January 2025)
- Targeting Microbiota and Metabolites for Prevention and Treatment of Human Diseases (Deadline: 31 January 2025)
- Research on Biomarkers for Cardiometabolic Risk in Metabolic Syndrome (Deadline: 10 February 2025)
- Immunometabolism and Metabolomics in Lung Disease (Deadline: 20 February 2025)
- Interplay Between Metabolic Adaptations to Physical Activity (Deadline: 20 February 2025)
- Role of Metabolic Factors and Their Interactions on Diabetes and Its Complications (Deadline: 28 February 2025)
- Adrenal Neuroendocrine System and Cardiometabolic Health (Deadline: 28 February 2025)
- Lifestyle Medicine for Chronic Diseases (Deadline: 28 February 2025)
- Adipose Tissue, Reproduction and Metabolic Health in Women (Deadline: 5 March 2025)
- Metabolic Research in Bladder Cancer (Deadline: 15 March 2025)
- Lifestyle Interventions: A Challenging Therapeutic Strategy for Metabolic Syndrome 2nd Edition (Deadline: 15 March 2025)
- Interactions of Diet, Exercise, and Metabolism (Deadline: 19 March 2025)
- Glucose Metabolism in Cardiovascular Diseases (Deadline: 31 March 2025)
- Role of Ceramides in Determining an Increased Cardiovascular and Renal Risk (Deadline: 31 March 2025)
- Obesity and Metabolic Dysfunction: Disease Development and Breaking the Cycle (Deadline: 31 March 2025)
- The Interplay Between Inflammation and Metabolism in Disease (Deadline: 31 March 2025)
- Exploring Potential Diagnostic and Prognostic Salivary Biomarkers in Cancer—2nd Edition (Deadline: 31 March 2025)
- Metabolic Biomarkers in Type 2 Diabetes: From Discovery to Application (Deadline: 2 April 2025)
- Environmental Exposure and Its Effects on Cardio-Respiratory and Metabolic Health (Deadline: 28 April 2025)
- Metabolites as Biomarkers for Inherited Disorders (Deadline: 30 April 2025)
- Gut Microbiota and Nutrient Metabolism Interactions in Metabolic Syndrome and Obesity (Deadline: 30 April 2025)
- Effects of Chemical Exposure on Endocrine and Reproductive Functions (Deadline: 30 April 2025)
- Impact of Microbial Metabolites on Intestinal Health and Diseases (Deadline: 30 April 2025)
- Mitochondrial Metabolism and Oxidative Stress in Hypertension, Diabetes and Related Complications (Deadline: 30 April 2025)
- Sex Differences in Physical Exercise and Dietary Habits Effects on Metabolic Health (Deadline: 5 May 2025)
- Risk Prediction and Novel Biomarker Discovery of Chronic Diseases by Advanced Methodologies in Lipidomics and Metabolomics (Deadline: 15 May 2025)
- Advances in Gut Microbiome Metabolomics (Deadline: 15 May 2025)
- Flavonoids: Novel Therapeutic Potential for Chronic Diseases (Deadline: 15 May 2025)
- Glucose Metabolism in Pregnancy (Deadline: 31 May 2025)
- Multimodal Approaches to Diagnosing Metabolic Bone Diseases (Deadline: 31 May 2025)
- Research of Inborn Errors of Metabolism (Deadline: 31 May 2025)
- Multiomics and Metabolism in Infectious Diseases and Cancer: Unveiling Novel Mechanisms and Biomarkers (Deadline: 31 May 2025)
- Stress and Inflammation: Drivers, Biomarkers and Physiological Effects (Deadline: 9 June 2025)
- Childhood Obesity and Its Associated Metabolic Complications (Deadline: 15 June 2025)
- Interactions between Exercise Physiology and Metabolism (Deadline: 20 June 2025)
- Mass Spectrometry-Based Metabolomics in Health and Disease: Targeted Analysis and Its Trends (Deadline: 30 June 2025)
- Metabolic Dysregulation in Fatty Liver Disease (Deadline: 30 June 2025)
- Cardiovascular Biomarkers and Metabolism in Cardiovascular Diseases (Deadline: 30 June 2025)
- Understanding Metabolic-Associated Fatty Liver Disease: Insights into Mechanisms and Management (Deadline: 30 June 2025)
- Advances in Metabolomics for Precision Medicine: From Biomarker Discovery to Clinical Applications (Deadline: 1 July 2025)
- Advancements in Reproductive Medicine: Unlocking the Secrets of the Ovary and Sperm for Fertility and Beyond (Deadline: 30 July 2025)
- Metabolism in Kidney Disease (Deadline: 31 July 2025)
- Primary Hyperparathyroidism: Mechanisms and Treatment (Deadline: 31 July 2025)
- The Multifaceted Roles of Biomarkers in Metabolic Disorders: From Diagnosis and Monitoring to Prediction, Management, and Treatment (Deadline: 15 August 2025)
- Effects of Nutrition and Exercise on Cardiometabolic Health (Deadline: 18 August 2025)
- Hyperlipidemia Related Endocrine Disease and Cancer in Human and Animal (Deadline: 31 August 2025)
- Metabolic Modulators in Cardiovascular Disease Management (Deadline: 31 August 2025)
- Metabolomics in Clinical Research: Advancing Precision Medicine Through the Analysis of Biological Samples (Deadline: 30 September 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
